Previous 10 | Next 10 |
Humana press release ( NYSE: HUM ): Q2 Non-GAAP EPS of $8.67 beats by $0.99 . Revenue of $23.72B (+15.3% Y/Y) beats by $280M . Updates FY 2022 EPS guidance to 'approximately $20.30' on a GAAP basis; raises to 'approximately $24.75' on an Adjusted basis, represe...
Reports 2Q22 earnings per diluted common share of $5.48 on a GAAP basis, Adjusted EPS of $8.67; reports YTD 2022 EPS of $12.77 on a GAAP basis, $16.70 on an Adjusted basis Updates FY 2022 EPS guidance to 'approximately $20.30' on a GAAP basis; raises to 'approximately $24.75' ...
Humana ( NYSE: HUM ) is scheduled to announce Q2 earnings results on Wednesday, July 27th, before market open. EPS Estimate is $7.68 (+11.5% Y/Y) and the consensus Revenue Estimate is $23.44B (+13.9% Y/Y). has beaten EPS estimates 100% of the time and has beaten revenue es...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a monthly...
Peak inflation will likely underpin stock market performance in the second half of the year, but at the same time equities are already pricing in a 40% chance of a recession, according to UBS. Looking for better risk/reward, the equities team is getting incrementally defensive by up...
Dividend growth stocks can make for attractive investments because the recurring income you receive has the potential to rise every year. But dividends are discretionary, and even if there is an increase, it may just be a nominal $0.02 hike -- especially if a company just wants to keep a st...
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
Elevance Health ( NYSE: ELV ), formerly known as Anthem, led a selloff among managed care players despite reporting better than expected financials for 2Q 2022 before the opening bell on Wednesday. Recording the sharpest intraday loss since March 2020, Elevance ( ELV ...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended June 30, 2022, Baron Health Care Fund declined 10.00% compared with the Benchmark. We are partic...
Humana ( NYSE: HUM ) plans to fill around 300 seasonal remote positions natiowide to support fall Medicare Annual Election Period. These Enrollment Representatives will serve for six months or less through the Medicare Advantage and Prescription Drug Plan open enrollme...
News, Short Squeeze, Breakout and More Instantly...
New collaboration will allow Humana to further modernize its cloud infrastructure and leverage Google Cloud’s Generative AI capabilities to accelerate innovation in healthcare. Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced a new multi-year agre...
Key investments with community partners expand options for historically unsupported populations Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), is investing in community-based organizations throughout Oklahoma to expan...
Lease agreement for new CenterWell Senior Primary Care and Conviva Care Centers locations will provide convenient primary care services designed especially for seniors. CenterWell, the health care services business of Humana Inc. (NYSE: HUM), today announced plans to lease clinical spac...